Literature DB >> 16627626

Nicotine attenuates beta-amyloid-induced neurotoxicity by regulating metal homeostasis.

Jie Zhang1, Qiang Liu, Qi Chen, Nian-Qing Liu, Fu-Liang Li, Zhong-Bing Lu, Chuan Qin, Hua Zhu, Yu-Ying Huang, Wei He, Bao-Lu Zhao.   

Abstract

Nicotine reduces beta-amyloidosis and has a beneficial effect against Alzheimer's disease (AD), but the underlying mechanism is not clear. The abnormal interactions of beta-amyloid (Abeta) with metal ions such as copper and zinc are implicated in the process of Abeta deposition in AD brains. In the present study, we investigated the effect of nicotine on metal homeostasis in the hippocampus and cortex of APP(V717I) (London mutant form of APP) transgenic mice. A significant reduction in the metal contents of copper and zinc in senile plaques and neuropil is observed after nicotine treatment. The densities of copper and zinc distributions in a subfield of the hippocampus CA1 region are also reduced after nicotine treatment. We further studied the mechanism of nicotine-mediated effect on metal homeostasis by using SH-SY5Y cells overexpressing the Swedish mutant form of human APP (APPsw). Nicotine treatment decreases the intracellular copper concentration and attenuates Abeta-mediated neurotoxicity facilitated by the addition of copper, and these effects are independent of the activation of nicotinic acetylcholine-receptor. These data suggest that the effect of nicotine on reducing beta-amyloidosis is partly mediated by regulating metal homeostasis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16627626     DOI: 10.1096/fj.05-5214fje

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  17 in total

1.  Huperzine A activates Wnt/β-catenin signaling and enhances the nonamyloidogenic pathway in an Alzheimer transgenic mouse model.

Authors:  Chun-Yan Wang; Wei Zheng; Tao Wang; Jing-Wei Xie; Si-Ling Wang; Bao-Lu Zhao; Wei-Ping Teng; Zhan-You Wang
Journal:  Neuropsychopharmacology       Date:  2011-02-02       Impact factor: 7.853

2.  Mitochondrial toxic effects of Aβ through mitofusins in the early pathogenesis of Alzheimer's disease.

Authors:  Zhaofei Wu; Yushan Zhu; Xingshui Cao; Shufeng Sun; Baolu Zhao
Journal:  Mol Neurobiol       Date:  2014-04-08       Impact factor: 5.590

3.  Nicotine reduces the cytotoxic effect of glycated proteins on microglial cells.

Authors:  Mohammad R Khazaei; Mostafa Bakhti; Mehran Habibi-Rezaei
Journal:  Neurochem Res       Date:  2009-11-28       Impact factor: 3.996

4.  Nicotine promotes survival of cells expressing amyloid precursor protein and presenilin: implication for Alzheimer's disease.

Authors:  Dwayne Brown; Carlana Ramlochansingh; Kebreten F Manaye; Yousef Tizabi
Journal:  Neurosci Lett       Date:  2013-01-08       Impact factor: 3.046

Review 5.  Natural antioxidants protect neurons in Alzheimer's disease and Parkinson's disease.

Authors:  Baolu Zhao
Journal:  Neurochem Res       Date:  2009-01-06       Impact factor: 3.996

Review 6.  Alpha7 nicotinic acetylcholine receptor: a link between inflammation and neurodegeneration.

Authors:  Concepcion Conejero-Goldberg; Peter Davies; Luis Ulloa
Journal:  Neurosci Biobehav Rev       Date:  2007-11-28       Impact factor: 8.989

7.  Zinc overload enhances APP cleavage and Aβ deposition in the Alzheimer mouse brain.

Authors:  Chun-Yan Wang; Tao Wang; Wei Zheng; Bao-Lu Zhao; Gorm Danscher; Yu-Hua Chen; Zhan-You Wang
Journal:  PLoS One       Date:  2010-12-17       Impact factor: 3.240

8.  Alzheimer's disease and cigarette smoke components: effects of nicotine, PAHs, and Cd(II), Cr(III), Pb(II), Pb(IV) ions on amyloid-β peptide aggregation.

Authors:  Cecilia Wallin; Sabrina B Sholts; Nicklas Österlund; Jinghui Luo; Jüri Jarvet; Per M Roos; Leopold Ilag; Astrid Gräslund; Sebastian K T S Wärmländer
Journal:  Sci Rep       Date:  2017-10-31       Impact factor: 4.379

Review 9.  Oxidative stress and the pathogenesis of Alzheimer's disease.

Authors:  Yan Zhao; Baolu Zhao
Journal:  Oxid Med Cell Longev       Date:  2013-07-25       Impact factor: 6.543

10.  Performance of motor associated behavioural tests following chronic nicotine administration.

Authors:  Omamuyovwi M Ijomone; Olayemi K Olaibi; Ifechukwude J Biose; Christian Mba; Kenneth E Umoren; Polycarp U Nwoha
Journal:  Ann Neurosci       Date:  2014-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.